InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: MeekMills post# 1516

Monday, 06/22/2020 12:40:52 PM

Monday, June 22, 2020 12:40:52 PM

Post# of 1739
Right, Weak hands are out, strong hands are holding stronger, because we didn't fall for the stupid shorts and bears scare tactics and false information, plus old old news. Shorts had fun with peeps whom don't do their own research, and for that, they rely on all the false information the shorts and bears feed them.

Here are some facts go to the company website and read for yourself.

Evoke Pharma inc Partnership with Eversana Science to handle all of Gimoti manufacturing, distribution, Commercialization, sales teams. In return Eversana get 20% of the profits generated by Gimoti and in return Evoke Pharma inc get a $5 million equity line of credit from Eversana after FDA approval of Gimoti, and Evoke Pharma inc gets 80% of Gimoti profits.

The contract deal can be cancel by both parties. A manufacture is part of a FDA approval for a drug. Evoke Pharma inc has already set the process up for a buyout and has $4.7 million in cash as of May 31 and a equity credit line for $5 million, Plus company is debt free. Great recipe set up for a buyout.

company only had 5 employees, so what in the devil they need with all that cash when they're not doing any manufacturing, distribution, commercialization, or hiring a sales team for Gimoti, all this is handle by Eversana, not Evoke Pharma Inc. They will just be getting paid like the shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News